Avid Bioservices Inc News

Craig-Hallum Sticks to Its Hold Rating for Avid Bioservices (CDMO)

TipRanksDec 11 21:50

Stephens Downgrades Avid Bioservices to Equalweight, Price Target Is $12.50

MT NewswiresDec 4 20:27

Craig-Hallum Sticks to Its Buy Rating for Avid Bioservices (CDMO)

TipRanksNov 7 22:08

Avid Bioservices Price Target Raised to $12.50/Share From $12.00 by RBC Capital

Dow JonesNov 7 20:19

Avid Bioservices Analyst Ratings

BenzingaNov 7 18:22

Stephens & Co. Reiterates Overweight on Avid Bioservices, Maintains $12 Price Target

BenzingaSep 10 21:55

Avid Bioservices Analyst Ratings

BenzingaSep 10 19:17

RBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)

TipRanksSep 10 18:41

Craig-Hallum Reaffirms Their Buy Rating on Avid Bioservices (CDMO)

TipRanksJul 16 21:01

Avid Bioservices Analyst Ratings

BenzingaJul 3 21:47

RBC Capital Reiterates Outperform on Avid Bioservices, Maintains $8 Price Target

BenzingaJul 3 21:47

RBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)

TipRanksJul 3 18:47

Avid Bioservices (CDMO) Receives a Buy From Craig-Hallum

TipRanksJul 1 21:32

Craig-Hallum Sticks to Their Buy Rating for Avid Bioservices (CDMO)

TipRanksMay 8 21:06

Royal Bank of Canada: Maintaining the Avid Bioservices (CDMO.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $7.00 to $8.00.

Zhitong FinanceMay 1 01:10

Avid Bioservices Analyst Ratings

BenzingaMay 1 01:10

RBC Capital Maintains Outperform on Avid Bioservices, Raises Price Target to $8

BenzingaMay 1 01:10

Analysts' Opinions Are Mixed on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Decibel Cannabis Company (OtherDBCCF) and Avid Bioservices (CDMO)

TipRanksApr 30 20:45

Analysts Offer Insights on Healthcare Companies: AIM ImmunoTech (AIM) and Avid Bioservices (CDMO)

TipRanksApr 30 18:45

Craig-Hallum Remains a Buy on Avid Bioservices (CDMO)

TipRanksApr 25 21:11